tiprankstipranks
Trending News
More News >
Adaptimmune Therapeutics (ADAPY)
OTHER OTC:ADAPY

Adaptimmune Therapeutics (ADAPY) Revenue

Compare
1,278 Followers

Adaptimmune Therapeutics Revenue

Adaptimmune Therapeutics had a revenue of 13.68M in the quarter ending Jun 30, 2025, with 87.74%. This bring the company's revenue in the last twelve months to 65.08M, Increased -63.77%. In the fiscal year ending Dec 31, 2024, Adaptimmune Therapeutics had annual revenue of 178.03M with 195.34% growth.
Revenue (ttm)
65.08M
Revenue Growth
-53.61%
P/S Ratio
0.06
Revenue/Employee
$351,842
Employees
506
Market Cap
$10.34M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
178.03M117.75M+295.34%
Dec 31, 2023
60.28M33.13M+222.05%
Dec 31, 2022
27.15M21.00M+441.50%
Dec 31, 2021
6.15M2.19M+155.36%
Dec 31, 2020
3.96M2.84M+352.76%
Dec 31, 2019
1.12M-58.38M+1.89%
Dec 31, 2018
59.51M21.67M+157.28%
Dec 31, 2017
37.83M23.64M+266.47%
Dec 31, 2016
14.20M